top of page

Our Pipeline

Our Platform technology, is designed to support a comprehensive portfolio of first in class products, delivered in both topical & oral formats. Our R&D efforts focus on areas, where significant unmet needs exists, and where the natural product has shown substantial efficacy in pre-clinical models and/or humans. 

Clinical Development Roadmap

Metabolic Syndrome & Obesity
Condition
Preclinical
Clinical 
Compound
 
IND-Enabling
DS 0111
Skin Aging Topicl
DS 0121
Skin Inflammatory. Conditions 
DS 0131
DS 0141
Mood Disorder
DS 0142
Cognitive Disoder
DS 0151
Solid Tumors
DS 0151
Atopic Dermatitis 
DS 0161
Respiratory
DS 0161
Mood & Skin

A Deeper Dive into our Product Proposals 

bottom of page